Pre-clinical models of infectious diseases task area a

Active Awarded Last action

Contract number
75N93024D00025
Awardee
Awarding agency
Task orders
1 $480,856 obligated

Award facts

Opportunity
Combined order value
  • $480,856 Current, with exercised options
  • $1,213,570 Potential, with all options
Last date to order 32% complete
IDV ceiling <1% used
$146,300,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 76 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The National Institute of Allergy and Infectious Diseases awarded a single-award indefinite-delivery contract to The Research Foundation For The State University Of New York on July 15, 2024, with a ceiling of $146.3 million and an ultimate completion date of July 14, 2031. The contract, titled "Pre-Clinical Models of Infectious Diseases," has no set-aside designation.

Work is performed in Syracuse, New York, and supports NIAID's mission to understand, treat, and prevent infectious, immunologic, and allergic diseases by providing preclinical models and specialized reagents for evaluating candidate medical countermeasures, including those targeting high-priority pathogens with pandemic potential.

The contract encompasses four task areas: small animal models of infectious diseases; non-human primate models of infectious diseases; animal replacement and non-traditional animal models of infectious diseases; and generation and distribution of specialized reagents. The IDV serves as a bridge between in vitro efficacy testing and clinical evaluation of therapeutic, vaccine, and diagnostic products, enabling rapid response to emerging infectious disease threats.

Recent delivery-order activity includes a $1.21 million firm fixed-price order awarded December 8, 2025, and completing December 7, 2028, for preclinical testing of candidate antiviral therapies against varicella-zoster virus and human cytomegalovirus using human skin xenograft mouse models and skin organ cultures under non-GLP conditions, performed in Syracuse.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00001 · EO14398 $0
Original award $0

Quick answers

Who was awarded contract 75N93024D00025?

75N93024D00025 was awarded to The Research Foundation For The State University Of New York by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 15, 2024.

How much is contract 75N93024D00025 worth?

Orders under 75N93024D00025 have obligated $480,856. Their combined potential value, with all options, is $1,213,570. 75N93024D00025's own ceiling is $146,300,000.

How many orders have been placed under contract 75N93024D00025?

1 order has been placed under 75N93024D00025, the latest on December 8, 2025.

Who can order from contract 75N93024D00025?

75N93024D00025 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract 75N93024D00025 part of a contract vehicle?

Yes. 75N93024D00025 is part of Pre-Clinical Models of Infectious Diseases.

Was contract 75N93024D00025 competed?

The extent of competition for 75N93024D00025 was full and open competition. The government received 76 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV